Differential Involvement of Thl and Th2 Cytokines in Autoimmune Diseases

References

• Kroemer G., Martínez A. C. Cytokines and autoimmune disease. Clin. Immunol. Immunopathol. 1991; 61: 275–295
   PubMedGoogle Scholar
• Holán V., Lamb J. R., Malkovsky M. Immunological tolerance and lymphokines. Crit. Rev. Immunol. 1991; 482: 481–493
   Google Scholar
• Cytokines and Autoimmunity. Sem. Immunol. 1992; 4(3)129–202, Kroemer, G., Martinez-A. C. (Eds.)
   Google Scholar
• Kroemer G. M., de Alboran I., Gonzalo J. A., Martinez A. C. Immunoregulation by cytokines. Crit. Rev. Immunol. 1993; 13: 163–191
   Google Scholar
• Mosmann T. R., Coffman R. L. THI and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989; 7: 145–173
   PubMed Web of Science ®Google Scholar
• Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol. Today 1991; 12: 256–257
   PubMedGoogle Scholar
• Paul W. E., Seder R. A. Lymphocyte responses and cytokines. Cell 1994; 76: 241–251
   PubMed Web of Science ®Google Scholar
• Fitch F. W., McKisic M. D., Lancki D. W., Gajewski T. F. Differential regulation of murine T lymphocyte subsets. Ann. Rev. Immunol. 1993; 11: 29–48
   PubMed Web of Science ®Google Scholar
• Powrie F., Coffman R. L. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today 1993; 14: 270–274
   PubMedGoogle Scholar
• Romagnani S. Lymphokine production by human T cells in disease states. Ann. Rev. Immunol. 1994; 12: 227–258
   PubMed Web of Science ®Google Scholar
• Clerici M., Shearer G. M. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 1994; 15: 575–581
   PubMedGoogle Scholar
• Caspi R. R., Roberge F. G., McAllister C. G., ElSaied M., Kuwabara T., Gery I., et al. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J. Immunol. 1986; 136: 928–933
   PubMed Web of Science ®Google Scholar
• Roberge F. G., Lorberboum-Galski H., Hoang P. L., de Smet M., Chan C. C., Fitzgerald D., et al. Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40: Inhibition of experimental autoimmune uveoretinitis. J. Immunol. 1989; 143: 3498–3502
   PubMed Web of Science ®Google Scholar
• Goldman M., Druet P., Gleichmann E. TH2 cells in systemic autoimmunity: insights from allogeneic dis-eases and chemically-induced autoimmunity. Immunol. Today 1991; 12: 223–227
   PubMedGoogle Scholar
• Saoudi A., Kuhn J., Huygen K., de Kozak Y., Velu T., Goldman M., et al. TH2 activate cells prevent experimental autoimmune uveoretinitis, a THI-dependent autoimmune disease. Eur. J. Immunol. 1993; 23: 3096–3103
   PubMed Web of Science ®Google Scholar
• Kühn R., Löhler J., Rennick D., Rajewsky K., Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263–274
   PubMed Web of Science ®Google Scholar
• Sadlack B., Merz H., Schorle H., Schimpl A., Feller A. C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Eur. J. Immunol. 1993; 75: 253–261
   Google Scholar
• Strober W., Ehrhardt R. O. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 1993; 75: 203–205
   Google Scholar
• Powrie F., Mason D. OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J. Exp. Med. 1990; 172: 1701–1708
   PubMed Web of Science ®Google Scholar
• Morrissey P. J., Charrier K., Braddy S., Liggitt D., Watson J. D. CD4 + T cells that express high level of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J. Exp. Med. 1993; 178: 237–244
   PubMed Web of Science ®Google Scholar
• Powrie F., Leach M. W., Mauze S., Caddle L. B., Coffman R. L. Phenotypically distinct subsets of CD4 + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 1993; 5: 1461–1471
   PubMed Web of Science ®Google Scholar
• Lee W. T., Yin X. M., Vitetta E. S. Functional and ontogenic analysis of murine CD45Rhi and CD45R10 CD4+ T cells. J. Immunol. 1990; 144: 3288–3295
   PubMed Web of Science ®Google Scholar
• McKnight A. J., Barclay A. N., Mason D. W. Molecular cloning of rat interleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4 + T cells. Eur. J. Immunol. 1991; 21: 1187–1194
   PubMed Web of Science ®Google Scholar
• Mustafa M., Vingsbo C., Olsson T., Ljungdahl A., Höjeberg B., Holmdahl R. The major histocompatibility complex influences myelin basic protein 63–88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis. Eur. J. Immunol. 1993; 23: 3089–3095
   Google Scholar
• Powell M. B., Mitchell D., Lederman J., Buckmeier J., Zamvil S. S., Graham M., et al. Lymphotoxin and tumor necrosis factor-alpha production by myelin basis protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 1990; 2: 539–544
   PubMed Web of Science ®Google Scholar
• Panitch H. S., Hirsch R. L., Schindler J., Johnson K. P. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurol. 1987; 37: 1097
   PubMed Web of Science ®Google Scholar
• Vecht C. J., Keohane C., Menon R. S., Henzenlogmans S. C., Punt C. J. A., Stoter G. Acute fatal leukoencephalopathy after interleukin treatment. N Engl. J. Med. 1990; 323: 1146–1147
   PubMed Web of Science ®Google Scholar
• Karpus W. J., Gould K. E., Swanbourg R. H. CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur. J. Immunol. 1992; 22: 1757–1763
   PubMed Web of Science ®Google Scholar
• Racke M. K., Bonomo A., Scott D. E., Cannella B., Levine A., Raine C. S., et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 1994; 180: 1961–1966
   PubMed Web of Science ®Google Scholar
• Khoury S. J., Hancock W. W., Weiner H. L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encepahlomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 1992; 176: 1355–1364
   PubMed Web of Science ®Google Scholar
• Kennedy M. K., Torrance D. S., Picha K. S., Mohler K. M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals IL-10 mRNA expression correlates with recovery. J. Immunol. 1992; 149: 2496–2505
   PubMed Web of Science ®Google Scholar
• Sarvetnick N., Shizuru J., Liggitt D., Martin L., McIntyre B., Gregory A., et al. Loss of pancreatic islet tolerance induced by β cell expression of interferon-g. Nature 1990; 346: 844–847
   PubMed Web of Science ®Google Scholar
• Allison J., Heath W., Miller J. F. A. P. Does interleukin-2 abrogate peripheral immunological self-tolerance in vivo. Sem Immunol. 1992; 4: 181–186
   Google Scholar
• Higuchi Y., Hetrera P., Huarte J., Belin D., Ohashi P., Aichele P., et al. Expression of a tumor necrosis factor alpha transgene in murine pancreatic p cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. 1992; 176: 1719–1731
   PubMed Web of Science ®Google Scholar
• Wogensen L., Huang X., Sarvetnick N. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Lamgerhans. J. Exp. Med. 1993; 178: 175–185
   PubMed Web of Science ®Google Scholar
• Allison J., Oxbrow L., Miller J. F. A. P. Consequences of in situ production of IL-2 for islet cell death. Int. Immunol. 1994; 6: 541–549
   PubMedGoogle Scholar
• Rapoport M. J., Jaramillo A., Zipris D., Lazarus A. H., Serreze D. V., Leiter E. H., et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 1993; 178: 87–99
   PubMed Web of Science ®Google Scholar
• Fowell D., McKnight A. J., Powrie F., Dyke R., Mason D. Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev. 1991; 123: 37–64
   PubMedGoogle Scholar
• Fowell D., Mason D. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J. Exp. Med. 1993; 177: 627–636
   PubMed Web of Science ®Google Scholar
• Bendelac A., Matzinger P., Seder R. A., Paul W. E., Schwartz R. H. Activation events during thymic selection. J. Exp. Med. 1992; 175: 731–742
   PubMed Web of Science ®Google Scholar
• Campbell I. L., Oxbrow L., Harrison L. C. Reduction in insulitis following administration of IFN-g and TNF-a in the NOD mouse. J. Autoimm. 1991; 4: 249–262
   PubMed Web of Science ®Google Scholar
• Alfons B., Heremans H., Vandekerckhove F., Dijk-mans R., Sobis H., Meulepas E., et al. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-g. J. Immunol. 1988; 140: 1506–1510
   Google Scholar
• Pankewycz O., Strom T. B., Rubin-Kelley Y. E. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes. Eur. J. Immunol. 1991; 21: 873–879
   PubMed Web of Science ®Google Scholar
• Pankewycz O. G., Guan J. X., Benedict J. F. A protective NOD islet-infiltrating CD8+ T cell clone, I.S.2.15, has in vitro immunosuppressive properties. Eur. J. Immunol. 1992; 22: 1017–1022
   Google Scholar
• Wicker L. S., Todd J. A., Prins J. B., Podolin P. L., Renjilian R. I., Peterson L. B. Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loco on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes. J. Exp. Med. 1994; 180: 1705–1713
   PubMed Web of Science ®Google Scholar
• de Wit D., van Mechelen M., Zanin C., Doutrelepont J. M., Velu T., Gérard C., et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J. Immunol. 1993; 150: 361–366
   PubMed Web of Science ®Google Scholar
• Gutierrez-Ramos J. C., Andreu J. L., Revilla Y., Viñuela E., Martinez A. C. Recovery from autoimmunity of MRL/1pr mice after infection with an interleukin-2/vaccinia recombinant virus. Nature 1990; 346: 271–274
   PubMed Web of Science ®Google Scholar
• Kroemer G., Andreu-Sanchez J. L., Gonzalo J. A., Gutierrez-Ramos J. C., Martinez A. C. Interleukin-2, autotolerance, and autoimmunity. Adv. Immunol. 1991; 150: 147–235
   Google Scholar
• Raveche E. S., Phillips J., Mahboudi F., Dang A, Fernandes H., Ramachandra S., et al. Regulatory aspects of clonally expanded B-1 (CD5+ B) cells. Int. J. Clin. Lab. Re, y. 1992; 22: 220–234
   Google Scholar
• Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp. Med. 1994; 179: 305–310
   PubMed Web of Science ®Google Scholar
• Gilliland B. C. Drug-induced autoimmune and hematologic disorders. Drug Allergy 1991; 11: 525–553
   Google Scholar
• Llorente L., Richaudpatin Y., Wijdenes J., Alcocer-Varela J., Maillo M. C., Durand-Gasselin I., et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. European Cytokine Network 1993; 4: 421–427
   PubMed Web of Science ®Google Scholar
• Gibbons R. B. Complication of chimiotherapy. A review of recent studies. Arch. Intern. Med. 1979; 46: 3343–3345
   Google Scholar
• Nakayama H., Niki F., Shono M., Hada S. Mercury exanthem. Contact Dermatitis 1983; 9: 411–417
   PubMed Web of Science ®Google Scholar
• Fillastre J. P., Druet P., Méry J. P. Proteinuric nephropaties associated with drugs and substances of abuse. The nephrotic syndrome, J. S. Cameron, R. J. Glassock. Dekker M, Basel, New York, 188: 697–744
   Google Scholar
• Dubey C., Bellon B., Hirsch F., Khun J., Vial M. C., Goldman M., et al. Increased expression of class II major histocompatibility complex molecules on B cells in rat suceptible or resistant to HgC12 -induced autoimmunity. Clin. Exp. Immunol. 1991; 86: 118–123
   PubMedGoogle Scholar
• Prigent P., Saoudi A., Druet P., Hirsch F. Mercuric chloride, a chemical responsible for Th2-mediated autoimmunity in Brown-Norway rats, directly triggers T cells to produce IL-4. J. Clin. Invest. 1995
   Google Scholar
• McKnight A. J., Classon B. J. Biochemical and immunological properties of rat recombinant interleukin-2 and interleukin-4. Immunology 1992; 75: 286–292
   Google Scholar
• Delespesse G., Suter U., Mossalayi D., Bettler B., Sarfati M., Hofstetter H., et al. Expression, structure, and function of the CD23 antigen. Adv. Imunol. 1990; 49: 149–191
   Google Scholar
• Burlingame R. W., Rubin R. L. Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J. Clin. Invest. 1981; 88: 680–690
   Google Scholar
• Hess E. V. Drug-related lupus. Curr. Opinion Rheumatol. 1991; 3: 809–814
   Google Scholar
• Quismorio F. P., Bjarnason D. F., Kiely W. F. Anti-nuclear antibodies in chronic psychotic patients treated with chlorpromazine. Am. J. Psychiatr. 1915; 132: 1204–1209
   Google Scholar
• Canoso R. T., deOliveira R. M. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis. Am. J. Hematol. 1988; 27: 272–277
   PubMed Web of Science ®Google Scholar
• Zucker S., Zarrabi H. M., Schubach W. H., Varma A., Derman R., Lysik R. M., et al. Chlorpromazine-induced immunopathy: progressive increase in serum 1gM. Medicine (Baltimore) 1990; 69: 92–100
   Google Scholar
• Roudebush R. E., Berry P. L., Layman N. K., Butler L. D., Bryant H. U. Dissociation of immunosuppression by chlorpromazine and trifluoperazine from pharmacological activities as dopamine antagonists. Int. J. Immunopharmacol. 1991; 13: 961–968
   Google Scholar
• Tarazona R., González-García A., Zamzami N., Frechin N., Gonzalo J. A., Ruiz-Gayo M., et al. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. J. Immunol. 1995, in press
   Google Scholar
• Moore K. W., O'Garra A., Malefyt R. W., Vieira P., Mosmann T. R. Interleukin 10. Ann. Rev. Immunol. 1993; 11: 165–190
   PubMed Web of Science ®Google Scholar
• Kroemer G., de Cid R., Moreno de Alboran N., Gonzalo J. A., Iglesias A., Martinez A. C., et al. Immunological self tolerance: an analysis employing cytokines or cytokine receptors encoded by transgenes or by a recombinant vaccinia virus. Immunol. Rev. 1991; 122: 183–204
   Google Scholar